Spyre Therapeutics Investor

Preclinical stage biotechnology companySpyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease ( Therapeutics, Inc. (SYRE) & Overview - /?